Research grants: Cornell SC Johnson College of Business "Innovation, Entrepreneurship, and Technology" inaugural travel grant, 2019-2020 Institute for Humane Studies Grant, 2018-2019 Cornell Graduate School Research Travel Grant, 2019įeatured in Written Description by Prof. Young Scholar Best Paper Award (economics/management), European Policy for Intellectual Property, ETH Zü rich, 9/2019 This paper is split (causal part) from an earlier draft at SSRN (unsplit) draft (paper & appendix) (unsplit) slides (60 min version)īest Paper Proceedings, Academy of Management (technology & innovation management division), 2021īest Student Paper award nominee, Antitrust Writing Awards, Concurrences, 2020īest Paper Award, Wharton Innovation Doctoral Symposium, University of Pennsylvania, 10/2019 Global Drug Diffusion and Innovation with the Medicines Patent Pool, 2022, Journal of Health Economicsĭownload: published version MPI discussion paper reading slides The MPP is now a key part of the WHO Covid-19 Technology Access Pool (C-TAP) Here is a summary of their contribution to drug access in Covid-19. Media: Twitter thread The Conversation India Education Diary HealthLawProf Blog ScienceX. We provided the first systematic analysis of the short-term performance via the HBP Forum. The HBP is a 10-year, €1 billion EU flagship project and one of the earliest brain initiatives. student menteeĭownload: published version MPI working paper. How would changes in legal institution s affect the rate and direction of innovation in restricted or illicit markets? In the cann abis market, legalization increases innovation, but not where it matters the most.Ĭollaborating Neuroscience Online: The Case of the Human Brain Project Forum, 2022, PLOS ONE, with Ann-Christin Kreyer * (Max Planck Institute for Innovation and Competition, and MGSE at LMU Munich, Germany) *co-author is a Ph.D. I s Grass Green er in the Gray Zone? Legalization and Innovation in the Cannabis Market, with Nathan Chan (UMass)ĭownload : latest draft (SSRN). Estimating the welfare gains generated from the MPP based on a structural model. Procurement Institutions and Essential Drug Supply in Low and Middle-Income Countries, w ith Nahim Bin Zahur (Queen's University, Canada) Reject & Resubmit, Management Scienceĭow nload: latest draft (SSRN) This paper s tudies the effectiveness and tra deoff of pooled procurement institutions (international & domestics) in facilitating LMIC drug supply heterogeneity and relative merits vs IP licensing institutionsĪ Cost-Benefit Analysis of the Medicines Patent Pool (a follow-up to Wang, JHE 2022 split from a longer version)ĭownload: latest draft (SSRN). Secondary: Industrial Organization, Public FinanceĪddress: Stockbridge Hall 208B, 80 Campus Center Way, Amherst 01003 Primary: Health Economics, Innovation Economics Economics (specialty: Insurance), CUFE, Beijing, China Economics, Duke University, Durham, NC, USAī.A. Economics, Cornell University, Ithaca, NY, USA My projects are funded by the Liu Memorial Fellowship from Cornell, Hayek Fund Awards, Humane Studies Fellowship, National Ministry of Education of China, among others. My research focuses on the economics of innovation & digitization in health care markets (national and global), particularly in the biopharmaceutical and digital health industries. I am a tenure-track Assistant Professor at University of Massachusetts Amherst, a Faculty Research Fellow at the Max Planck Institute for Innovation and Competition, Germany, and a Faculty Associate at the Canadian Centre for Health Economics.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |